Chemours Revenue Slightly Declines
Chemours Q2 sales fell 1% to $1.591 billion amid lower Opteon refrigerant demand, though adjusted net profit reached $64 million meeting analyst expectations with free cash flow up 128%.
ccin · 2026-08-10 00:00
3 articles
Chemours Q2 sales fell 1% to $1.591 billion amid lower Opteon refrigerant demand, though adjusted net profit reached $64 million meeting analyst expectations with free cash flow up 128%.
Chemours maintained its 2026 outlook despite lower aftermarket refrigerant sales, reporting flat Q2 net sales of $1.591 billion. Adjusted EBITDA in its Thermal & Specialized Solutions segment rose 3%,
Chemours Co declared a quarterly cash dividend of $0.0875 per share for the third quarter of 2026, payable on September 15, 2026. The global industrial and specialty chemicals leader continues its sha